CRDL
Cardiol Therapeutics·NASDAQ
--
--(--)
--
--(--)
CRDL fundamentals
Cardiol Therapeutics (CRDL) released its earnings on Nov 13, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -0.09 (YoY +32.45%), missed estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.09
+32.45%
Report date
Nov 13, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Cardiol Therapeutics (CRDL) key financial stats and ratios, covering profitability, financial health, and leverage.
Cardiol Therapeutics (CRDL)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Cardiol Therapeutics (CRDL)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cardiol Therapeutics (CRDL)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Cardiol Therapeutics (CRDL) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Cardiol Therapeutics (CRDL) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Cardiol Therapeutics’s earnings call?What factors drove the changes in Cardiol Therapeutics's revenue and profit?What is the market's earnings forecast for Cardiol Therapeutics next quarter?What is Cardiol Therapeutics's latest dividend and current dividend yield?What guidance did Cardiol Therapeutics's management provide for the next earnings period?What were the key takeaways from Cardiol Therapeutics's earnings call?Did Cardiol Therapeutics beat or miss consensus estimates last quarter?What does Cardiol Therapeutics do and what are its main business segments?
